Common Adverse Events Associated with the Use of Ribavirin for Severe Acute Respiratory Syndrome in Canada

Clinical Infectious Diseases

Volumn 37, Issue 8, 2003, Pages 1139-1142

  Knowles, Sandra R ^a,c   Phillips, Elizabeth J ^a,c   Dresser, Linda ^b,c   Matukas, Larissa ^c  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; AZITHROMYCIN; BILIRUBIN; CALCIUM; CEFTRIAXONE; CORTICOSTEROID; CREATINE KINASE; ERYTHROPOIETIN; HAPTOGLOBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; LEVOFLOXACIN; MAGNESIUM; RIBAVIRIN;

ACUTE RESPIRATORY TRACT DISEASE; ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD TRANSFUSION; CANADA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATINE KINASE BLOOD LEVEL; DOSE RESPONSE; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRUG USE; ELECTROLYTE DISTURBANCE; FEMALE; HEMOGLOBIN DETERMINATION; HEMOLYTIC ANEMIA; HUMAN; HYPOCALCEMIA; HYPOMAGNESEMIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MUSCLE SPASM; MUSCLE TWITCH; PRIORITY JOURNAL; SEVERE ACUTE RESPIRATORY SYNDROME; TETANY; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, HEMOLYTIC; ANTIVIRAL AGENTS; CANADA; DISEASE OUTBREAKS; FEMALE; HUMANS; HYPOCALCEMIA; MALE; MIDDLE AGED; RIBAVIRIN; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 0142218449     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/378304     Document Type: Article

References (20)

1. World Health Organization. Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS). 26 May 2003. Available at: http://www.who.int/csr/sars/country/2003_05_26/en/. Accessed on 27 May 2003.
2. Sidwell R, Huffman H, Khare J. Broad spectrum antiviral activity of virazole: b-d-ribofuranosyl 1-2-4 triaxole-3-carboxamide. Science 1972; 177:705-6.
3. Dominguez K, Mercier R. Treatment of RSV pneumonia in adults - evidence of ribavirin effectiveness? Ann Pharmacother 1999; 33:739-41.
4. American Academy of Pediatrics Committee on Infectious Diseases. Use of ribavirin in the treatment of respiratory syncytial virus infection. Pediatrics 1993; 92:501-4.
5. McHutchison J, Gordon S, Schiff E, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485-92.
6. Huggins J, Hsiang C, Cosgriff T, et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis 1991; 164: 1119-27.
7. McCormick J, King I, Webb P, et al. Lassa fever: effective therapy with ribavirin. N Engl J Med 1986; 314:20-6.
8. Health Canada. Severe acute respiratory syndrome (SARS): definition of persons under investigation. 30 May 2003. Available at: http://www .hc-sc.gc.ca/pphb-dgspsp/sars-sras/sars-pui_e.html. Accessed 4 September 2003.
9. Tsang K, Ho P, Ooi G, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348:1977-85.
10. Peiris J, Chu C, Cheng V, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003; 361:1767-72.
11. Chang C, Chen K, Lai M, Chan K. Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C. Aliment Pharmacol Ther 2002; 16:1623-32.
12. Talal A, Weisz K, Hau T, Kreisworth S, Dieterich D. A preliminary study of erythropoietin for anemia associated with ribavirin and interferon-α. Am J Gastroenterol 2001; 96:2802-3.
13. Chutaputti A. Adverse effects and other safety aspects of the hepatitis C antivirals. J Gastroenterol Hepatol 2000; 15(Suppl):E156-63.
14. Pockros P, Reindollar RJ, Reddy R, Wright T, Boyd D, Wilkes L. The safety and tolerability of daily infergen plus ribavirin in the treatment of naive chronic hepatitis C patients. J Viral Hepat 2003; 10:55-60.
15. Forni A, Schluger N, Roberts R. Severe measles pneumonitis in adults: evaluation of clinical characteristics and therapy with intravenous ribavirin. Clin Infect Dis 1994; 19:454-62.
16. Ribavirin: new preparation. An advance, but still no cure-all. Prescrire Int 2000; 9:72-5.
17. Glue P. The clinical pharmacology of ribavirin. Semin Liver DIs 1999; 19:17-14.
18. Severe acute respiratory syndrome (SARS) and coronavirus testing - United States, 2003. MMWR Morb Mortal Wkly Rep 2003; 52: 297-302. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/ mm5214a1.htm. Accessed 27 May 2003.
19. Health Canada Onine. Update #43: severe acute respiratory syndrome. 29 April 2003. Available at: http://www.hc-sc.gc.ca/english/protection/ warnings/sars/update43.html Accessed 27 May 2003.
20. Booth C, Matukas L, Tomlinson G, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003; 289:2801-9.